A detailed history of Advisor Group Holdings, Inc. transactions in Organovo Holdings, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,032 shares of ONVO stock, worth $485. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,032
Previous 1,032 -0.0%
Holding current value
$485
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.75 - $1.35 $696 - $1,252
-928 Reduced 47.35%
1,032 $0
Q1 2024

May 10, 2024

SELL
$0.9 - $1.17 $141 - $183
-157 Reduced 7.42%
1,960 $2,000
Q4 2023

Feb 12, 2024

SELL
$1.05 - $1.84 $693 - $1,214
-660 Reduced 23.77%
2,117 $2,000
Q3 2023

Nov 13, 2023

BUY
$1.06 - $1.9 $471 - $845
445 Added 19.08%
2,777 $3,000
Q2 2023

Aug 21, 2023

SELL
$1.64 - $2.24 $37 - $51
-23 Reduced 0.98%
2,332 $3,000
Q2 2023

Aug 10, 2023

SELL
$1.64 - $2.24 $874 - $1,193
-533 Reduced 18.46%
2,355 $3,000
Q1 2023

May 12, 2023

BUY
$1.44 - $3.2 $151 - $336
105 Added 3.77%
2,888 $6,000
Q4 2022

Feb 10, 2023

SELL
$1.41 - $2.17 $315 - $486
-224 Reduced 7.45%
2,783 $3,000
Q3 2022

Nov 14, 2022

SELL
$1.76 - $3.55 $176 - $355
-100 Reduced 3.22%
3,007 $6,000
Q2 2022

Aug 10, 2022

BUY
$1.71 - $3.71 $222 - $482
130 Added 4.37%
3,107 $5,000
Q1 2022

May 04, 2022

SELL
$2.74 - $4.41 $5,274 - $8,489
-1,925 Reduced 39.27%
2,977 $12,000
Q3 2021

Nov 05, 2021

SELL
$6.08 - $8.92 $10,852 - $15,922
-1,785 Reduced 26.69%
4,902 $34,000
Q2 2021

Aug 02, 2021

BUY
$6.65 - $9.95 $3,990 - $5,970
600 Added 9.86%
6,687 $63,000
Q1 2021

May 13, 2021

SELL
$8.67 - $21.7 $1,612 - $4,036
-186 Reduced 2.97%
6,087 $59,000
Q4 2020

Feb 10, 2021

BUY
$7.19 - $17.05 $5,787 - $13,725
805 Added 14.72%
6,273 $77,000
Q3 2020

Nov 12, 2020

BUY
$6.27 - $15.8 $34,284 - $86,394
5,468 New
5,468 $44,000

Others Institutions Holding ONVO

About ORGANOVO HOLDINGS, INC.


  • Ticker ONVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,712,020
  • Market Cap $4.09M
  • Description
  • Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...
More about ONVO
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.